bimagrumab

bimagrumab
Trade Name
Orphan Indication Inclusion Body Myositis
USA Market Approval USA
USA Designation Date 2012-06-18 00:00:00
Sponsor Novartis Pharmaceuticals Corp.;One Health Plaza;East Hanover, New Jersey, 07936